Funding Details
- Awarder
- SOSV
- Date Award
- May 13, 2024
- Vertical
- Biopharma
- Funding URL
- View Funding Page
Company Info
- Founders
- Paul Feldstein, LeAnn Lindsay, James Lincoln
- Company Description
- Circularis has developed a powerful and novel method to regulate gene expression to increase minimum bio-therapeutic production yields by up to ten times. We can do this for any gene in any species with no prior knowledge of the regulatory elements or coding sequence. Circularis is the only company that can deliver optimized gene expression and increased production yields for any protein from any species.
- Market
- Human Health
- Location
-
United States
Links